ArticleBlood neoplasia2026

CD20 negativity at the start of second-line therapy predicts a shorter overall survival in B-cell lymphomas.

Sanaz Mehdi Gholy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.